Neurocysticercosis: Diagnosis and Management of Patients Living in the United States
On this Page
- Technical Requirements
- Accreditation Statements
- For Continuing Medical Education for Physicians (CME)
- Continuing Education designated for Non Physicians
- Continuing Nursing Education for Nurses (NE)
- Instructions for Completing Posttest & Evaluation Online
- Author/Developer Information
- Contact Information
- Disclosure Statement
This course is designed to educate clinicians about neurocysticercosis (NCC) in the United States. Lesson 1 will cover basic epidemiology of the disease, including life cycle of Taenia solium (the causative agent), risk factors for acquiring the disease, the burden of disease, and prevention of the disease. Lesson 2 will discuss presentation, diagnosis, and evaluation techniques for patients with NCC. Lesson 3 will describe appropriate management of patients with NCC. Lesson 4 will include three case studies, to present an opportunity to think critically about diagnosis and management of NCC, particularly in complex cases.
For Continuing Medical Education for Physicians (CME):
The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this educational activity for a maximum of (1.5) AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Continuing Education designated for Non-Physicians:
Non-physicians will receive a certificate of participation.
Continuing Nursing Education for Nurses (CNE)
The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (1.3) contact hours.
Instructions for Obtaining Continuing Education (CE)
In order to receive continuing education (CE) for WB2528 – Neurocysticercosis: Diagnosis and Management of Patients Living in the United States please visit TCEO and follow these 9 Simple Steps before April 1, 2020.
This course will expire April 1, 2020.
The author of this course is Paul Cantey, MD, MPH of the Division of Parasitic Diseases and Malaria. Developers of this course are Sharon Hall, PhD, RN, Susan P. Montgomery, DVM, MPH, and Kelly Stimpert, MPH.
For assistance with registration, completing the course assessment and posttest, transcripts, and printing continuing education certificates, please contact OWCD Training and Continuing Education. OWCD can be reached via:
Please email firstname.lastname@example.org with any questions regarding this course.
CDC, our planners, our presenters , and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Lesson 3 discussion on treatment of viable and non-viable parenchymal cysts with praziquantel, a drug which is FDA approved but not for treatment of neurocysticercosis. Lesson 3 will review suggested treatment and considerations for patients with parenchymal cysts.
CDC does not accept commercial support.
FEES: No fees are charged for CDC’s CE activities.